Impianti S.P.A. (BIT:MPT)

Intra-Cellular Therapies Income Statement

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	6.46	3.71	5.7	4.35	5.19
Revenue Growth (YoY)	73.99%	-34.87%	31.20%	-16.33%	38.91%
Cost of Revenue	3.61	1.56	3.23	2.17	2.6
Gross Profit	2.85	2.16	2.48	2.18	2.6
Selling, General & Admin	1.11	1.08	1.01	1.01	1.18
Other Operating Expenses	1.39	0.88	1.27	0.98	1.25
Operating Expenses	2.54	2.01	2.33	2.05	2.48
Operating Income	0.31	0.15	0.14	0.12	0.12
Interest & Investment Income	0	0	0.02	0	0
Other Non Operating Income (Expenses)	-0.01	-0.01	-0.03	-0.02	-0.03
Pretax Income	0.3	0.14	0.14	0.1	0.09
Income Tax Expense	0.08	0.04	0.05	0.04	0.01
Earnings From Continuing Operations	0.22	0.1	0.09	0.06	0.08
Net Income	0.22	0.1	0.09	0.06	0.08
Net Income Growth	124.49%	8.89%	50.00%	-26.83%	-
Gross Margin	44.10%	58.13%	43.42%	50.09%	50.00%
Operating Margin	4.81%	4.07%	2.53%	2.85%	2.33%
Profit Margin	3.40%	2.64%	1.58%	1.38%	1.58%
EBITDA	0.36	0.2	0.2	0.18	0.17
EBITDA Margin	5.53%	5.25%	3.42%	4.21%	3.31%
EBIT	0.31	0.15	0.14	0.12	0.12
EBIT Margin	4.81%	4.07%	2.53%	2.85%	2.33%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.